164
Participants
Start Date
October 31, 2007
Primary Completion Date
June 30, 2009
Study Completion Date
June 30, 2009
Varespladib (A-002)
250mg tablets BID for 3-5 days pre-angioplasty and 5 days post-angioplasty.
placebo
250mg tablets BID 3-5 days pre-angioplasty and 5 days post-angioplasty.
Toronto General Hospital, Toronto
Collaborators (1)
Anthera Pharmaceuticals
INDUSTRY
University Health Network, Toronto
OTHER